VSEE · XBRL financial data
VSee Health financial statements, every fiscal year
The same tables from 7 filings, lined up. Matched by XBRL tag: renamed lines keep their history.
How these numbers work
- Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
- Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
- * marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
- 0 means a filing states zero; a dash (—) means no filing states that number.
- “year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
- Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
- Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
- Shares outstanding come from each filing's cover page, as of the date printed there.
- Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.
Income statement
CSVFiscal years (VSEE's year ends in late December)
| In thousands of dollars | Dec 31, 2022 | Dec 31, 2023 | Dec 31, 2024 | Dec 31, 2025 |
|---|---|---|---|---|
| Revenue | — | — | 10,421 | 14,618 |
| Revenue from contracts with customers | — | 5,766 | 10,421 | 14,618 |
| Cost of revenue | — | 1,933 | 3,244 | 7,262 |
| Gross profit | — | 3,833 | 7,178 | 7,356 |
| General and administrative | — | 1,202 | 6,554 | 10,037 |
| Total operating expenses | — | 5,706 | 69,328 | 16,939 |
| Operating income (loss) | (3,595) | (2,594) | (62,151) | (9,583) |
| Interest income | 923 | 359 | — | — |
| Interest expense | 126 | 191 | 211 | 2,812 |
| Other income (expense) | — | (20) | 1 | 47 |
| Income tax expense (benefit) | 187 | 1,838 | (1,643) | 68 |
| Net income (loss) | (3,243) | (4,414) | (57,702) | (14,713) |
| Earnings per share, basic‡ USD per share | (0.10) | (0.43) | (5.65) | (0.73) |
| Earnings per share, diluted‡ USD per share | (0.10) | (0.43) | (5.65) | (0.73) |
| Weighted average shares, basic‡ thousands of shares | 31,853 | 10,241 | 10,213 | 20,143 |
| Weighted average shares, diluted‡ thousands of shares | 31,853 | 10,241 | 10,213 | 20,143 |
- ‡ Per-share figures and share counts are adjusted for the 2.5-for-1 stock split (June 2024); filings made before it reported them unadjusted.
Balance sheet
CSVFiscal years (VSEE's year ends in late December)
| In thousands of dollars | Dec 31, 2022 | Dec 31, 2023 | Dec 31, 2024 | Dec 31, 2025 |
|---|---|---|---|---|
| Cash and cash equivalents | 107 | 2 | 326 | 5,266 |
| Accounts receivable | — | 603 | 1,716 | 2,521 |
| Prepaid and other current assets | — | 80 | 447 | 274 |
| Total current assets | 107 | 2 | 3,021 | 8,365 |
| Property and equipment, net | — | 4 | 680 | 333 |
| Right-of-use asset | — | — | 380 | 13 |
| Goodwill | — | — | 4,917 | 4,917 |
| Total assets | 7,634 | 1,371 | 19,992 | 22,413 |
| Accounts payable | — | 417 | 4,283 | 5,528 |
| Accrued liabilities | 74 | — | — | — |
| Current portion of long-term debt | — | 220 | 434 | 1,242 |
| Total current liabilities | 3,296 | 7,984 | 19,010 | 16,245 |
| Long-term debt | — | — | 594 | 594 |
| Lease liability, non-current | — | — | 269 | 3 |
| Total liabilities | 7,666 | 12,354 | 20,011 | 16,961 |
| Accumulated deficit | (7,720) | (12,816) | (67,704) | (82,417) |
| Total stockholders' equity | (7,427) | (12,266) | (18) | — |
| Total liabilities and equity | 7,634 | 1,371 | 19,992 | 22,413 |
| Common shares outstanding (cover page)‡ thousands of shares | 10,440 | 9,010 | 16,423 | 47,299 |
- ‡ Per-share figures and share counts are adjusted for the 2.5-for-1 stock split (June 2024); filings made before it reported them unadjusted.
Cash flows
CSVFiscal years (VSEE's year ends in late December)
| In thousands of dollars | Dec 31, 2022 | Dec 31, 2023 | Dec 31, 2024 | Dec 31, 2025 |
|---|---|---|---|---|
| Net income (loss) | (3,243) | (4,414) | (57,702) | (14,713) |
| Net cash from operating activities | (1,391) | (962) | (5,790) | (3,446) |
| Purchases of property and equipment | — | 4 | 55 | 30 |
| Net cash from investing activities | 110,122 | 6,517 | (26) | (30) |
| Proceeds from issuing common stock | — | — | 0 | 1,500 |
| Share repurchases | 110,472 | 6,796 | 5 | 0 |
| Net cash from financing activities | (109,384) | (5,661) | 6,023 | 8,416 |
| Net change in cash | (653) | (105) | 207 | 4,940 |
Compare with peers
SIC 8000 and related industry codes, similar size. Each row is the latest quarter reported.
How peers are chosen
- SIC 8000 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
- Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
- Runway shows only for companies burning cash with under $10B of public float.
- * marks a quarter worked out from the filing totals: for a 10-K, the year less the first three quarters; for a 10-Q, the year-to-date total less the earlier one.
| Company | Cash ($K) | Revenue, quarter ($K) | Operating cash flow, quarter ($K) | Shares outstanding | Runway | Quarter |
|---|---|---|---|---|---|---|
| Vsee Health | 454 | 1,562 | (1,174)* | 56.7M | 0.4 quarters | 10-QJun 30, 2026 |
| P3 Health Partners | 21,272 | 386,381 | (61,914)* | not reported | 0.3 quarters | 10-QJun 30, 2026 |
| Longduoduo | 1,589 | 631* | 275* | 30.0M | — | 10-KJun 30, 2026 |
| Agape ATP | 45 | 109 | (110)* | 1.0M | 0.4 quarters | 10-QJun 30, 2026 |
Not investment advice. Not affiliated with the U.S. SEC.